leucine has been researched along with Opsoclonus-Myoclonus Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clough, C; Kulendran, A; Kyaw, KM; Legister, A; MacFarlane, G; Mulroy, E; Patel, M; Sankar, UU; Smyth, D | 1 |
1 other study(ies) available for leucine and Opsoclonus-Myoclonus Syndrome
| Article | Year |
|---|---|
Post-COVID-19 opsoclonus-myoclonus syndrome and encephalopathy associated with leucine-rich glioma-inactivated 1 (LGI-1) antibodies.
Topics: Brain Diseases; COVID-19; Glioma; Humans; Leucine; Opsoclonus-Myoclonus Syndrome; SARS-CoV-2 | 2021 |